Ozempic-like drug fails to treat Parkinson's disease in new study; here's what the scientists said
Semaglutide, the drug used in Ozempic, has been linked to lowering the risk of Alzheimer's disease in the past. So, it was ...
MedPage Today2d
FDA OKs New Wearable Treatment for Parkinson's Disease
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
FDA approves wearable infusion device for advanced Parkinson disease
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
Healio2d
FDA approves Onapgo for motor fluctuations in adults with Parkinson’s disease
The FDA has approved Onapgo, the first subcutaneous apomorphine device to treat motor fluctuations in adults with Parkinson’s disease, according to the manufacturer.In a press release, Supernus ...
Forbes1y
Novel Approaches To Treat Parkinson’s Disease May Signal A Turning Point
Degeneration of this structure is characteristic of Parkinson's disease. In late 2018, Japanese neurosurgeons at Kyoto University Hospital implanted reprogrammed stem cells into the brain of a ...